Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
22 results
D1.297 - Clinical characteristics of red meat allergy in 19 cases in Jeju
D1.289 - The buzz that nearly broke a heart: A case of Kounis Syndrome following a Hymenoptera sting
D1.292 - Anaphylaxis After Roasted Sunflower Seed Consumption in an Adult: A Case Report
D1.293 - Hidden allergens revealed by prick-to-prick testing: anaphylaxis triggered by black pepper and cumin
D1.295 - Patient Perceived Lifestyle Burden with a Nasal Adrenaline Spray vs an Adrenaline Auto- Injector
D1.296 - Nasal Adrenaline Spray vs Adrenaline Auto-Injectors: When Will People Act?
D1.298 - Does Previous Anaphylaxis Determine Differences between Patients Undergoing Oral Food Challenges to Cow’s Milk and Hen’s Egg?
D1.301 - Non-specific lipid transfer protein allergy: the culprit in disguise
D1.302 - Allergic Reactions Following Measles-Mumps-Rubella Vaccination in Children with Food Allergy: A Single Center Experience
D1.481 - Prevalence of Immunoglobulin Deficiency in Patients with Chronic Rhinosinusitis Followed in a Tertiary Referral Center
D1.487 - Evaluation of Large Language Models in Otolaryngology: Accuracy on Structured Question Banks and S.C.O.R.E.-Based Interpretation of Guidelines and Consensus Statements
D1.485 - Characterization of CRSwNP and associated Type 2 or Respiratory comorbidities in the biological era in Spain - The POLARIS study
D1.490 - Dupilumab in the treatment of Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Cystic Fibrosis patients
D1.492 - Efficacy and safety of a combined nasal spray with a fixed dose of mometasone and olopatadine for the treatment of allergic rhinitis in pets under save ongoing exposure to epidermal allergens
D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies
D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection
D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper
D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use
D2.455 - Does Biological Therapy Modify NSAID Hypersensitivity? Experience with Omalizumab and Mepolizumab in Patients with Asthma and Nasal Polyps with N-ERD
D2.456 - Chronic sinusitis with nasal polyposis: Add-on aspirin desensitization useful in dupilumab therapy?
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download